Necrotizing Enterocolitis: Clinical Trials

8 trials for Necrotizing Enterocolitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

8 completed. 8 Phase 2, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 28Completed 8
Phase 14Completed 4

Follow Necrotizing Enterocolitis: new trials by email Literature Review of Necrotizing Enterocolitis trials Research Report on Necrotizing Enterocolitis

Trials (filtered) newest first · largest first

All 8 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RIC-NEC Randomized Controlled Trial
Remote ischemic conditioning (RIC) + Standard of Care for NEC, Standard of Care for NEC - Necrotizing Enterocolitis
Phase 2CompletedThe Hospital for Sick Children862023-02-092026-11-03
Efficacy Of Oral Melatonin To Prevent Necrotizing Enterocolitis
Melatonin 6 MG, Breast Milk - Necrotizing Enterocolitis
Phase 1 / Phase 2CompletedIlocos Training and Regional Medical Center1002021-03-012024-06-20
IBP-9414 for the Prevention of Necrotizing Enterocolitis
IBP-9414, Placebo - Necrotizing Enterocolitis
Phase 2CompletedInfant Bacterial Therapeutics1202016-05-272017-12-29
Early Treatment Versus Delayed Conservative Treatment of the Patent Ductus Arteriosus
pharmacologic treatment of the PDA, no pharmacologic treatment of the PDA, NSAID - Patent Ductus Arteriosus, Surgery
Phase 2CompletedUniversity of California, San Francisco2022013-12-012018-11-30
Enteral Administration of Docosahexaenoic Acid to Prevent Necrotizing Enterocolitis in Preterm Neonates
Docosahexaenoic acid (DHA), Placebo - Necrotizing Enterocolitis
Phase 1 / Phase 2CompletedCoordinación de Investigación en Salud, Mexico2252012-10-012021-03-24
Enteral Granulocyte Colony Stimulating Factor and Erythropoietin Early in Life Increases Feeding Tolerance in Preterm Infants: A Randomized Controlled Trial
recombinant human G-CSF, and rhEPO, rh G-CSF, rh EPO - Feeding Intolerance, Necrotizing Enterocolitis
Phase 1 / Phase 2CompletedAin Shams University932010-01-012011-09-27
Pharmacokinetic (PK) and Safety Study of Meropenem in Young Infants With Intra-abdominal Infections
meropenem - Necrotizing Enterocolitis, Intra-abdominal Infection
Phase 1 / Phase 2CompletedThe Emmes Company, LLC2002008-06-012023-04-25
Lactulose Supplementation in Premature Infants
Lactulose, Dextrose - Necrotizing Enterocolitis, Sepsis
Phase 2CompletedBnai Zion Medical Center282005-02-012008-02-15

Narrower conditions

Enterocolitis, Necrotizing (8)  ·  Premature Birth (2)  ·  Ductus Arteriosus, Patent (1)  ·  Intestinal Perforation (1)  ·  Intraabdominal Infections (1)  ·  Sepsis (1)

Broader conditions

Digestive System Diseases (8)  ·  Enterocolitis (8)  ·  Gastroenteritis (8)  ·  Gastrointestinal Diseases (8)  ·  Intestinal Diseases (8)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Infections (2)  ·  Obstetric Labor Complications (2)  ·  Obstetric Labor, Premature (2)  ·  Pregnancy Complications (2)  ·  Urogenital Diseases (2)  ·  Cardiovascular Abnormalities (1)  ·  Cardiovascular Diseases (1)  ·  Congenital Abnormalities (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)

Interventions

Anti-Inflammatory Agents, Non-Steroidal (1)  ·  Docosahexaenoic Acids (1)  ·  Fatty Acids, Omega-3 (1)  ·  Glucose (1)  ·  Lactulose (1)  ·  Melatonin (1)  ·  Meropenem (1)  ·  Milk, Human (1)  ·  Standard of Care (1)  ·  Sunflower Oil (1)

Sponsors

Ain Shams University (1)  ·  Bnai Zion Medical Center (1)  ·  Coordinación de Investigación en Salud, Mexico (1)  ·  Ilocos Training and Regional Medical Center (1)  ·  Infant Bacterial Therapeutics (1)  ·  The Emmes Company, LLC (1)  ·  The Hospital for Sick Children (1)  ·  University of California, San Francisco (1)

Countries

United States (4)  ·  Canada (1)  ·  Israel (1)  ·  Mexico (1)  ·  Philippines (1)  ·  Sweden (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Agostino Pierro, OBE, MD (1)  ·  Arieh Riskin, MD (1)  ·  Daisy Evangeline C Garcia, MD (1)  ·  Danny Benjamin, MD, PhD, MPH (1)  ·  Josef Neu, MD (1)  ·  Mariela Bernabe-Garcia, PhD (1)  ·  Navid P Roodaki, MD (1)  ·  Ron Shaoul, MD (1)  ·  Ronald Clyman, MD (1)

Results publications

PMID 22955430, PMID 25155966, PMID 30340932, PMID 30850756, PMID 31255386, PMID 33671220